31 results
8-K
EX-10.1
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
) the European Union (“EU”) Clinical Trials Regulation (Regulation (EU) No. 536/2014); (vi) the EU Regulation regarding community procedures for authorization
S-3ASR
EX-4.4
v621m1 773
14 Sep 23
Automatic shelf registration
5:28pm
8-K
EX-1.1
btxp7
7 Jun 23
Day One Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
ygo8a10p 4to
7 Jun 23
Prospectus supplement for primary offering
4:57pm
424B5
tm7k9cv5kubp3ml h8e
6 Jun 23
Prospectus supplement for primary offering
4:21pm
8-K
EX-1.1
yd1jeoo
16 Jun 22
Day One Announces Pricing of Upsized Public Offering of Common Stock
7:33am
424B5
j2xva uur
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
iywcfb1fwh7kif p7m1
14 Jun 22
Prospectus supplement for primary offering
7:39am
S-3
EX-1.2
a6vf3
1 Jun 22
Shelf registration
4:06pm
S-3
EX-4.4
ggznz3s6 fjf
1 Jun 22
Shelf registration
4:06pm